These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The significance of BAP1 and MTAP/CDKN2A expression in well-differentiated papillary mesothelial tumour: a series of 21 cases and a review of the literature. Hassan A, Prabhakaran S, Pulford E, Hocking AJ, Godbolt D, Ziad F, Pandita A, Wessels A, Hussey M, Russell PA, Klebe S. Pathology; 2024 Aug; 56(5):662-670. PubMed ID: 38789301 [Abstract] [Full Text] [Related]
4. Mesothelioma: morphologic and immunohistochemical findings. Churg A. Pathologie (Heidelb); 2024 Sep; 45(5):309-315. PubMed ID: 38568257 [Abstract] [Full Text] [Related]
8. Usefulness of methylthioadenosine phosphorylase and BRCA-associated protein 1 immunohistochemistry in the diagnosis of malignant mesothelioma in effusion cytology specimens. Berg KB, Churg AM, Cheung S, Dacic S. Cancer Cytopathol; 2020 Feb; 128(2):126-132. PubMed ID: 31821740 [Abstract] [Full Text] [Related]
11. A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis. Kinoshita Y, Hamasaki M, Yoshimura M, Matsumoto S, Sato A, Tsujimura T, Ueda H, Makihata S, Kato F, Iwasaki A, Nabeshima K. Lung Cancer; 2018 Nov; 125():198-204. PubMed ID: 30429020 [Abstract] [Full Text] [Related]
14. A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma. Kinoshita Y, Hida T, Hamasaki M, Matsumoto S, Sato A, Tsujimura T, Kawahara K, Hiroshima K, Oda Y, Nabeshima K. Cancer Cytopathol; 2018 Jan; 126(1):54-63. PubMed ID: 29053210 [Abstract] [Full Text] [Related]
15. Loss of Methylthioadenosine Phosphorylase by Immunohistochemistry Is Common in Pulmonary Sarcomatoid Carcinoma and Sarcomatoid Mesothelioma. Terra S, Roden AC, Yi ES, Aubry MC, Boland JM. Am J Clin Pathol; 2022 Jan 06; 157(1):33-39. PubMed ID: 34463336 [Abstract] [Full Text] [Related]